The audit of Research and Development facility of Aurigene Discovery Technologies Limited, a wholly owned subsidiary of Dr. Reddy's Laboratories Ltd, situated at Miyapur, Hyderabad by the US FDA, has been completed on March 21, 2019. No FDA 483 was issued at the end of inspection.
Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.2750 as compared to the previous close of Rs. 2747.25. The total number of shares traded during the day was 18489 in over 1175 trades.
The stock hit an intraday high of Rs. 2775.05 and intraday low of 2740. The net turnover during the day was Rs. 50934764.